Our top pick for
MaxLinear, Inc is a semiconductors business based in the US. MaxLinear shares (MXL) are listed on the NYSE and all prices are listed in US Dollars. MaxLinear employs 1,420 staff and has a trailing 12-month revenue of around USD$478.6 million.
|52-week range||USD$7.79 - USD$44.05|
|50-day moving average||USD$36.0518|
|200-day moving average||USD$29.9055|
|Wall St. target price||USD$42.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.299|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing MaxLinear stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MaxLinear's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MaxLinear's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1234. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MaxLinear's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MaxLinear's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$22.6 million.
The EBITDA is a measure of a MaxLinear's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$478.6 million|
|Gross profit TTM||USD$245.7 million|
|Return on assets TTM||-3.62%|
|Return on equity TTM||-24.46%|
|Market capitalisation||USD$2.8 billion|
TTM: trailing 12 months
There are currently 2.5 million MaxLinear shares held short by investors – that's known as MaxLinear's "short interest". This figure is 2.7% up from 2.4 million last month.
There are a few different ways that this level of interest in shorting MaxLinear shares can be evaluated.
MaxLinear's "short interest ratio" (SIR) is the quantity of MaxLinear shares currently shorted divided by the average quantity of MaxLinear shares traded daily (recently around 729356.50887574). MaxLinear's SIR currently stands at 3.38. In other words for every 100,000 MaxLinear shares traded daily on the market, roughly 3380 shares are currently held short.
However MaxLinear's short interest can also be evaluated against the total number of MaxLinear shares, or, against the total number of tradable MaxLinear shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MaxLinear's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 MaxLinear shares in existence, roughly 30 shares are currently held short) or 0.0427% of the tradable shares (for every 100,000 tradable MaxLinear shares, roughly 43 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MaxLinear.
Find out more about how you can short MaxLinear stock.
We're not expecting MaxLinear to pay a dividend over the next 12 months.
Over the last 12 months, MaxLinear's shares have ranged in value from as little as $7.79 up to $44.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MaxLinear's is 2.0667. This would suggest that MaxLinear's shares are significantly more volatile than the average for this exchange and represent a higher risk.
MaxLinear, Inc. provides radiofrequency (RF), high-performance analog, and mixed-signal communications systems-on-chip solutions (SoCs) for the connected home, wired and wireless infrastructure, and industrial and multi-market applications worldwide. Its products integrate various portions of a high-speed communication system, including radiofrequency (RF), high-performance analog, mixed-signal, digital signal processing, security engines, data compression, networking layers, and power management. The company offers broadband radio transceiver front ends, data converters, embedded systems and software architecture, and architecture and system design for highly integrated end-to-end communication platform solutions. Its products are used in various electronic devices, such as cable data over cable service interface specifications (DOCSIS), fiber and DSL broadband modems and gateways; Wi-Fi and wireline routers for home networking; radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; and fiber-optic modules for data center, metro, and long-haul transport networks, as well as power management and interface products. It serves electronics distributors, module makers, original equipment manufacturers (OEMs), and original design manufacturers (ODMs) through a direct sales force, third-party sales representatives, and a network of distributors. MaxLinear, Inc. has a collaboration with Facebook Connectivity to integrate silicon technologies and radio processing algorithms into Evenstar radio units. The company was founded in 2003 and is headquartered in Carlsbad, California.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.